Synthesis and comparative biological evaluation of l- and d-isomers of 18F-labeled fluoroalkyl phenylalanine derivatives as tumor imaging agents

Nuclear Medicine and Biology

Volumn 38, Issue 3, 2011, Pages 301-312

  Wang, Limin ^a   Lieberman, Brian P ^a   Plössl, Karl ^a   Qu, Wenchao ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

18F; D Amino acids; LATs; PET; Phenylalanine derivatives; Tumor imaging

Indexed keywords

2 (2 FLUOROETHYL) DEXTRO TYROSINE F 18; 2 (2 FLUOROETHYL)TYROSINE F 18; 4 (2 FLUOROETHYL) DEXTRO PHENYLALANINE F 18; 4 (2 FLUOROETHYL)PHENYLALANINE F 18; AMINO ACID TRANSPORTER; PHENYLALANINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPROTECTION REACTION; FLUORINATION; GLIOMA CELL; IMAGE QUALITY; IN VITRO STUDY; IN VIVO STUDY; ISOMERISM; NONHUMAN; NUCLEOPHILICITY; POSITRON EMISSION TOMOGRAPHY; RAT; SYNTHESIS; TUMOR MODEL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; FLUORINE RADIOISOTOPES; GLIOMA; PHENYLALANINE; POSITRON-EMISSION TOMOGRAPHY; RATS; STEREOISOMERISM; TYROSINE;

EID: 79954418398     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2010.10.004     Document Type: Article

References (44)

1. Ganapathy V., Thangaraju M., Prasad P.D. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 2009, 121:29-40.
2. McConathy J., Goodman Mark M. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Rev 2008, 27:555-573.
3. Jager P.L., Vaalburg W., Pruim J., de Vries E.G., Langen K.J., Piers D.A. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001, 42:432-445.
4. Singhal T., Narayanan T.K., Jain V., Mukherjee J., Mantil J. 11C-l-Methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 2008, 10:1-18.
5. Langen K.J., Pauleit D., Coenen H.H. 3-[123I]Iodo-a-methyl-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2002, 29:625-631.
6. Langen K.J., Jarosch M., Hamacher K., Muhlensiepen H., Weber F., Floeth F., et al. Imaging of gliomas with cis-4-[18F]fluoro-l-proline. Nucl Med Biol 2004, 31:67-75.
7. Koerts J., Leenders K.L., Koning M., Portman A.T., van Beilen M. Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease. Eur J Neurosci 2007, 25:3132-3136.
8. Schuster D.M., Votaw J.R., Nieh P.T., Yu W., Nye J.A., Master V., et al. Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma. J Nucl Med 2007, 48:56-63.
9. Langen K.J., Hamacher K., Weckesser M., Floeth F., Stoffels G., Bauer D., et al. O-(2-[18F]Fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2006, 33:287-294.
10. Wester H.J., Herz M., Weber W., Heiss P., Senekowitsch-Schmidtke R., Schwaiger M., et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-l-tyrosine for tumor imaging. J Nucl Med 1999, 40:205-212.
11. Laverman P., Boerman O.C., Corstens F.H., Oyen W.J. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med Mol Imaging 2002, 29:681-690.
12. McGivan J.D., Pastor-Anglada M. Regulatory and molecular aspects of mammalian amino acid transport. Biochem J 1994, 299(Pt 2):321-334.
13. Fuchs B.C., Bode B.P. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?. Semin Cancer Biol 2005, 15:254-266.
14. Saier M.H., Daniels G.A., Boerner P., Lin J. Neutral amino acid transport systems in animal cells: potential targets of oncogene action and regulators of cellular growth. J Membr Biol 1988, 104:1-20.
15. Kaira K., Oriuchi N., Imai H., Shimizu K., Yanagitani N., Sunaga N., et al. l-Type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci 2008, 99:2380-2386.
16. Christensen H.N. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 1990, 70:43-77.
17. Tamemasa O., Goto R., Suzuki T. Preferential incorporation of some 14C-labeled d-amino acids into tumor-bearing animals. Gann 1978, 69:517-523.
18. Friedman M. Chemistry, nutrition, and microbiology of d-amino acids. J Agric Food Chem 1999, 47:3457-3479.
19. Kanai Y., Segawa H., Miyamoto K., Uchino H., Takeda E., Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998, 273:23629-23632.
20. Uchino H., Kanai Y., Kim D.K., Wempe M.F., Chairoungdua A., Morimoto E., et al. Transport of amino acid-related compounds mediated by l-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol 2002, 61:729-737.
21. Yanagida O., Kanai Y., Chairoungdua A., Kim D.K., Segawa H., Nii T., et al. Human l-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 2001, 1514:291-302.
22. Segawa H., Fukasawa Y., Miyamoto K., Takeda E., Endou H., Kanai Y. Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 1999, 274:19745-19751.
23. Nawashiro H., Otani N., Shinomiya N., Fukui S., Ooigawa H., Shima K., et al. l-Type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer 2006, 119:484-492.
24. Sakata T., Ferdous G., Tsuruta T., Satoh T., Baba S., Muto T., et al. l-Type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Pathol Int 2009, 59:7-18.
25. Kaira K., Oriuchi N., Imai H., Shimizu K., Yanagitani N., Sunaga N., et al. Prognostic significance of l-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. Br J Cancer 2008, 98:742-748.
26. Bergstrom M., Lundqvist H., Ericson K., Lilja A., Johnstrom P., Langstrom B., et al. Comparison of the accumulation kinetics of l-(methyl-11C)-methionine and d-(methyl-11C)-methionine in brain tumors studied with positron emission tomography. Acta Radiol 1987, 28:225-229.
27. Heiss P., Mayer S., Herz M., Wester H.J., Schwaiger M., Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-l-tyrosine in vitro and in vivo. J Nucl Med 1999, 40:1367-1373.
28. Tsukada H., Sato K., Fukumoto D., Kakiuchi T. Evaluation of d-isomers of O-F-18-fluoromethyl, O-F-18-fluoroethyl and O-F-18-fluoropropyl tyrosine as tumour imaging agents in mice. Eur J Nucl Med Mol Imaging 2006, 33:1017-1024.
29. Bauwens M., Lahoutte T., Kersemans K., Gallez C., Bossuyt A., Mertens J. Comparison of the uptake of [123/125I]-2-iodo-d-tyrosine and [123/125I]-2-iodo-l-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo. Nucl Med Biol 2006, 33:735-741.
30. Kersemans V., Cornelissen B., Bacher K., Kersemans K., Thierens H., Dierckx R.A., et al. In vivo evaluation and dosimetry of 123I-2-iodo-d-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model. J Nucl Med 2005, 46:2104-2111.
31. Langen K.J., Hamacher K., Bauer D., Broer S., Pauleit D., Herzog H., et al. Preferred stereoselective transport of the d-isomer of cis-4-[18F]fluoro-proline at the blood-brain barrier. J Cereb Blood Flow Metab 2005, 25:607-616.
32. Langen K.J., Salber D., Hamacher K., Stoffels G., Reifenberger G., Pauleit D., et al. Detection of secondary thalamic degeneration after cortical infarction using cis-4-18F-fluoro-d-proline. J Nucl Med 2007, 48:1482-1491.
33. Makrides V., Bauer R., Weber W., Wester H.J., Fischer S., Hinz R., et al. Preferred transport of O-(2-[18F]fluoroethyl)-d-tyrosine (D-FET) into the porcine brain. Brain Res 2007, 1147:25-33.
34. Wang L., Qu W., Lieberman B.P., Plössl K., Kung H.F. Synthesis, uptake mechanism characterization and biological evaluation of 18F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents. Nucl Med Bio 2010, (in press, doi:10.1016/j.nucmedbio.2010.07.005).
35. Yu W., Williams L., Camp V.M., Olson J.J., Goodman M.M. Synthesis and biological evaluation of anti-1-amino-2-[18F]fluoro-cyclobutyl-1-carboxylic acid (anti-2-[18F]FACBC) in rat 9L gliosarcoma. Bioorg Med Chem Lett 2010, 20:2140-2143.
36. Hamacher K., Coenen H.H. Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-l-tyrosine. Appl Radiat Isot 2002, 57:853-856.
37. Smith G., Sivakua T. Mechanism of the racemization of amino acids. Kinetics of racemization of arylglycines. J Org Chem 1983, 48:627-634.
38. Urakami T., Sakai K., Asai T., Fukumoto D., Tsukada H., Oku N. Evaluation of O-[(18)F]fluoromethyl-d-tyrosine as a radiotracer for tumor imaging with positron emission tomography. Nucl Med Biol 2009, 36:295-303.
39. Palacin M., Estevez R., Bertran J., Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 1998, 78:969-1054.
40. Bodoy S., Martin L., Zorzano A., Palacin M., Estevez R., Bertran J. Identification of LAT4, a novel amino acid transporter with system L activity. J Biol Chem 2005, 280:12002-12011.
41. Tomi M., Mori M., Tachikawa M., Katayama K., Terasaki T., Hosoya K. l-Type amino acid transporter 1-mediated l-leucine transport at the inner blood-retinal barrier. Invest Ophthalmol Vis Sci 2005, 46:2522-2530.
42. Babu E., Kanai Y., Chairoungdua A., Kim D.K., Iribe Y., Tangtrongsup S., et al. Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem 2003, 278:43838-43845.
43. Tsukada H., Sato K., Fukumoto D., Nishiyama S., Harada N., Kakiuchi T. Evaluation of d-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with l- and d-11C-methionine. J Nucl Med 2006, 47:679-688.
44. Kersemans V., Cornelissen B., Kersemans K., Bauwens M., Dierckx R.A., De Spiegeleer B., et al. 123/125I-Labelled 2-iodo-l: -phenylalanine and 2-iodo-d: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice. Eur J Nucl Med Mol Imaging 2006, 33:919-927.